Application of metabolic data to the evaluation of drugs. A report prepared by the committee on problems of drug safety of the drug research board, National Academy of Sciences-National Research Council.
D000047:Academies and Institutes; D000818:Animals; D002273:Carcinogens / Q000494:pharmacology; D002415:Cats; D004285:Dogs; D004336:Drug Antagonism; D004357:Drug Synergism; D004358:Drug Therapy; D004790:Enzyme Induction; D004798:Enzymes / Q000378:metabolism; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D007408:Intestinal Absorption; D007422:Intestines / Q000382:microbiology; D008099:Liver / Q000201:enzymology; D008722:Methods; D051379:Mice; D004364:Pharmaceutical Preparations / Q000378:metabolism* / Q000592:standards; D010597:Pharmacogenetics; D010600:Pharmacology; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D012106:Research; D013045:Species Specificity; D014481:United States; D014486:United States Food and Drug Administration; D014944:World Health Organization; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D002273:Carcinogens; D004798:Enzymes; D004364:Pharmaceutical Preparations; D011955:Receptors, Drug; D014969:Xanthine Oxidase